• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤流行病学。

Epidemiology of Melanoma.

机构信息

Harvard T.H. Chan School of Public Health, Kresge Building Room 718, 677 Huntington Ave, Boston, MA 02115, USA; Department of Internal Medicine, East Carolina University/Vidant Medical Center, 600 Moye Boulevard, MA-350, Greenville, NC 27834, USA.

Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Kresge Building, Room 718, 677 Huntington Avenue, Boston, MA 02115, USA.

出版信息

Hematol Oncol Clin North Am. 2021 Feb;35(1):57-72. doi: 10.1016/j.hoc.2020.08.011. Epub 2020 Oct 26.

DOI:10.1016/j.hoc.2020.08.011
PMID:33759773
Abstract

Please add expansion for AL. Melanoma is the most common fatal type of skin cancer and is an important and growing public health problem in the United States, Australia, New Zealand, and Europe. The mortality rate in most of the world has been rising as well, albeit slower than that for incidence. Likely due to the availability of new treatments for stage 4 melanoma, mortality rates in the United States dropped 18% from 2013 to 2016. We further describe trends in melanoma incidence and mortality, review the literature on risk factors, and provide an up-to-date assessment of population-wide screening and some of the inherent concerns.

摘要

请对 AL 进行扩展。黑色素瘤是最常见的致命皮肤癌类型,也是美国、澳大利亚、新西兰和欧洲的一个重要且日益严重的公共卫生问题。尽管发病率的上升速度比死亡率快,但在世界上大多数地区,死亡率也一直在上升。可能是由于新的 4 期黑色素瘤治疗方法的出现,美国的死亡率从 2013 年到 2016 年下降了 18%。我们进一步描述了黑色素瘤发病率和死亡率的趋势,回顾了有关危险因素的文献,并对全人群筛查及其一些固有问题进行了最新评估。

相似文献

1
Epidemiology of Melanoma.黑色素瘤流行病学。
Hematol Oncol Clin North Am. 2021 Feb;35(1):57-72. doi: 10.1016/j.hoc.2020.08.011. Epub 2020 Oct 26.
2
Epidemiology and Screening for Melanoma.黑色素瘤的流行病学和筛查。
Hematol Oncol Clin North Am. 2024 Oct;38(5):889-906. doi: 10.1016/j.hoc.2024.05.003. Epub 2024 Jun 21.
3
Melanoma Diagnoses Rise While Mortality Stays Fairly Flat, Raising Concerns About Overdiagnosis.黑色素瘤诊断率上升,而死亡率基本持平,引发了对过度诊断的担忧。
JAMA. 2020 Apr 21;323(15):1429-1430. doi: 10.1001/jama.2020.2669.
4
Melanoma screening: Informing public health policy with quantitative modelling.黑色素瘤筛查:通过定量建模为公共卫生政策提供信息。
PLoS One. 2017 Sep 25;12(9):e0182349. doi: 10.1371/journal.pone.0182349. eCollection 2017.
5
Melanoma screening by physicians: time for a policy change in the United States.医生进行黑色素瘤筛查:美国是时候改变政策了。
JAMA Dermatol. 2014 Oct;150(10):1045-6. doi: 10.1001/jamadermatol.2014.1326.
6
Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030.生命体征:美国1982 - 2030年黑色素瘤发病率、死亡率趋势及预测
MMWR Morb Mortal Wkly Rep. 2015 Jun 5;64(21):591-6.
7
Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).德国北莱茵-威斯特法伦州在全国性皮肤癌筛查计划(2000-2015 年)前后的皮肤癌发病率。
Eur J Epidemiol. 2018 Mar;33(3):303-312. doi: 10.1007/s10654-017-0348-6. Epub 2018 Jan 2.
8
Incidence, mortality and survival in cutaneous melanoma.皮肤黑色素瘤的发病率、死亡率和生存率。
J Plast Reconstr Aesthet Surg. 2007;60(1):32-40. doi: 10.1016/j.bjps.2006.05.008. Epub 2006 Jul 7.
9
The Rapid Rise in Cutaneous Melanoma Diagnoses.皮肤黑色素瘤诊断数量的迅速上升。
N Engl J Med. 2021 Jan 7;384(1):72-79. doi: 10.1056/NEJMsb2019760.
10
Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions.黑色素瘤的筛查、早期检测及趋势:当前状况(2000 - 2006年)与未来方向
J Am Acad Dermatol. 2007 Oct;57(4):555-72; quiz 573-6. doi: 10.1016/j.jaad.2007.06.032.

引用本文的文献

1
Diagnostic System for Early In Situ Melanoma Detection Using Acoustic Microscopy and Infrared Spectroscopic Mapping Imaging.基于声学显微镜和红外光谱映射成像的早期原位黑色素瘤诊断系统
Cancers (Basel). 2025 Aug 7;17(15):2599. doi: 10.3390/cancers17152599.
2
pH-Sensitive TRPC5 Is Differentially Expressed in Various Common Skin Tumors.pH敏感的瞬时受体电位通道蛋白5在各种常见皮肤肿瘤中差异表达。
Biology (Basel). 2025 Jul 7;14(7):823. doi: 10.3390/biology14070823.
3
Characterization of Melanoma in Hungary Based on a Retrospective Single-Center Study Between 2001 and 2018.
基于2001年至2018年一项回顾性单中心研究的匈牙利黑色素瘤特征分析
Cancers (Basel). 2025 Jun 27;17(13):2171. doi: 10.3390/cancers17132171.
4
Liquid biopsy as a potential tool for diagnosis and clinical monitoring of cutaneous and uveal melanoma.液体活检作为皮肤和葡萄膜黑色素瘤诊断及临床监测的潜在工具。
J Liq Biopsy. 2025 Jun 14;9:100306. doi: 10.1016/j.jlb.2025.100306. eCollection 2025 Sep.
5
Molecular and immune landscape of melanoma: a risk stratification model for precision oncology.黑色素瘤的分子与免疫格局:精准肿瘤学的风险分层模型
Discov Oncol. 2025 May 4;16(1):667. doi: 10.1007/s12672-025-02497-0.
6
Exploiting Paradoxical Activation of Oncogenic MAPK Signaling by Targeting Mitochondria to Sensitize Mutant-Melanoma to Vemurafenib.通过靶向线粒体利用致癌性丝裂原活化蛋白激酶(MAPK)信号的矛盾激活使突变型黑色素瘤对维莫非尼敏感
Int J Mol Sci. 2025 Mar 16;26(6):2675. doi: 10.3390/ijms26062675.
7
97 Machine learning algorithms in the prognosis of cutaneous melanoma: a population-based study.97 种机器学习算法在皮肤黑色素瘤预后中的应用:一项基于人群的研究。
Discov Oncol. 2025 Mar 17;16(1):342. doi: 10.1007/s12672-025-02129-7.
8
HDAC/σ1R Dual-Ligand as a Targeted Melanoma Therapeutic.组蛋白去乙酰化酶/σ1受体双配体作为靶向性黑色素瘤治疗药物
Pharmaceuticals (Basel). 2025 Jan 28;18(2):179. doi: 10.3390/ph18020179.
9
[Disease burden and trend of melanoma among middle-aged and elderly population in China from 1990 to 2020, and prediction for 2022 to 2035].1990年至2020年中国中老年人群黑色素瘤的疾病负担及趋势,以及2022年至2035年的预测
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 Jan 25;54(1):1-9. doi: 10.3724/zdxbyxb-2024-0385.
10
Systematic Automated Population-Based Surveillance to Improve Outcomes in Primary Cutaneous Melanoma.基于人群的系统性自动监测以改善原发性皮肤黑色素瘤的治疗结果
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241306298. doi: 10.1177/21501319241306298.